Nafoxidine is a triphenylethylene nonsteroidal agent that functions as a partial estrogen antagonist. Nafoxidine competes with endogenous estrogen for binding to specific estrogen receptors. This agent also inhibits angiogenesis in some tissues by blocking the effects of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF); paradoxically, it may enhance angiogenesis in uterine tissue. Nafoxidine also induces oxidative stress, protein kinase C and calcium signaling. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Nafoxidina, Nafoxidinum, 1-[2-[4-(6-methoxy-2-phenyl-3 and 4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine. Its PubChem CID is 4416.
Nafoxidine
| CAS No | 1845-11-0 |
|---|---|
| Molecular Formula | C29H31NO2 |
| Molecular Weight | 425.6 g/mol |
| Synonyms | 1-[2-[4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nafoxidine is a triphenylethylene nonsteroidal agent that functions as a partial estrogen antagonist. Nafoxidine competes with endogenous estrogen for binding to specific estrogen receptors.
The listed CAS number is 1845-11-0.
The listed molecular formula is C29H31NO2.
The listed molecular weight is 425.6 g/mol.
1-[2-[4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine.
The source lists Nafoxidina, Nafoxidinum, 1-[2-[4-(6-methoxy-2-phenyl-3 and 4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine.